Skip to main content
Log in

Musculoskeletal disease research funding justified in UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2013 British pounds

Reference

  • Glover M, et al. Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes. Health Research Policy and Systems : 10 Jan 2018. Available from: URL: https://doi.org/10.1186/s12961-017-0276-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Musculoskeletal disease research funding justified in UK. PharmacoEcon Outcomes News 795, 21 (2018). https://doi.org/10.1007/s40274-018-4659-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4659-y

Navigation